+ All Categories
Home > Documents > Situation épidémiologique de l’infection à...

Situation épidémiologique de l’infection à...

Date post: 04-Feb-2020
Category:
Upload: others
View: 2 times
Download: 0 times
Share this document with a friend
19
Session 1
Transcript
Page 1: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Session 1

Page 2: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Module goals

Page 3: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Module 2: Natural history and clinical aspects

natural history and clinical aspects

Mod

ule

1 M

odul

e 2

Mod

ule

3 M

odul

e 4

Participants will be able to: -offer an insight into the epidemiological situation in the country and worldwide -present the HIV transmission modes and the broad approaches to prevention -implement post-exposure prophylaxis for HIV in the health care environment.

Participants will be able to: -describe the natural history of the HIV infection -expose the main circumstances in which the HIV infection is discovered -describe some of the clinical manifestations of the HIV/AIDS infection.

Participants will be able to: - name the techniques used for the biological diagnosis of the HIV infection - argue the need to comply with ethical and confidentiality imperatives in the health care environment - name the interventions to reduce HIV stigma and discrimination in health care settings.

Participants will be able to: - inform a PLHIV about how care is organized in the country - inform a PLHIV about the principles of care - inform parents about the care available for a newborn baby, infant or child infected by HIV - argue the need for optimal adherence to antiretroviral therapy.

Page 4: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Module 2: Natural history and clinical aspects

natural history and clinical aspects

Mod

ule

1 M

odul

e 2

Mod

ule

3 M

odul

e 4

Participants will be able to: -offer an insight into the epidemiological situation in the country and worldwide -present the HIV transmission modes and the broad approaches to prevention -implement post-exposure prophylaxis for HIV in the health care environment.

Participants will be able to: -describe the natural history of the HIV infection -expose the main circumstances in which the HIV infection is discovered -describe some of the clinical manifestations of the HIV/AIDS infection.

Participants will be able to: - name the techniques used for the biological diagnosis of the HIV infection - argue the need to comply with ethical and confidentiality imperatives in the health care environment - name the interventions to reduce HIV stigma and discrimination in health care settings.

Participants will be able to: - inform a PLHIV about how care is organized in the country - inform a PLHIV about the principles of care - inform parents about the care available for a newborn baby, infant or child infected by HIV - argue the need for optimal adherence to antiretroviral therapy.

Page 5: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Natural history of the HIV infection

Page 6: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Module 2: Natural history and clinical aspects

natural history and clinical aspects

Natural history

Exposure Infection No infection Primary infection Asymptomatic HIV-positive

10 years later

- Non-progressor 5%–10% - Minor infections 20% - AIDS 70%

Page 7: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Module 2: Natural history and clinical aspects

natural history and clinical aspects

Evolution of CD4 and viral load

years

200

4 8 2 10

Page 8: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Module 2: Natural history and clinical aspects

natural history and clinical aspects

Two essential parameters (CD4 and viral load)

Viral load

Speed

Page 9: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Module 2: Natural history and clinical aspects

natural history and clinical aspects

Destruction of CD4

Normal HIV infection

CD4 CD4

Page 10: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Module 2: Natural history and clinical aspects

natural history and clinical aspects

Consequences of the reduction of CD4 T lymphocytes

Immune system intact

Immune system destroyed

Loss of defence mechanisms

Page 11: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Module 2: Natural history and clinical aspects

natural history and clinical aspects

Clinical and biological correlation

years

200

Tumours

Opportunistic infections

4 8

AIDS

2 10

PI Asymptomatic Minor infections

HIV encephalitis

Page 12: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Module 2: Natural history and clinical aspects

natural history and clinical aspects

Rate of CD4 decline and occurrence of Opportunistic Infections

years

200

Candidiasis

Herpes Zoster

Kaposi’s sarcoma

Lymphoma

Pneumocystosis

Toxoplasmosis

CMV Atypical

mycobacterioses

4 8

AIDS

2 10

PI Asymptomatic

Page 13: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Module 2: Natural history and clinical aspects

natural history and clinical aspects

• Can modify the natural history of HIV infection

• Can inhibit viral multiplication and consequently restore cell

immunity

Antiretroviral therapy

Page 14: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Classifications of HIV infection

Page 15: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Module 2: Natural history and clinical aspects

natural history and clinical aspects

Rate of CD4 decline and occurrence of opportunistic infections

years

200

Candidiasis

Herpes Zoster

Kaposi’s sarcoma

Lymphoma

Pneumocystosis

Toxoplasmosis

CMV

4 8

AIDS

2 10

PI Asymptomatic

Atypical mycobacterioses

Page 16: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Module 2: Natural history and clinical aspects

natural history and clinical aspects

Cases of HIV infection are classified as follows

•According to clinical manifestations: primary infection,

general signs, minor infections, opportunistic infections, HIV-

related tumours…

•According to degree of immunodeficiency: CD4 T lymphocyte

count

•According to age: adults and adolescents, children

Basis of classification

Page 17: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Module 2: Natural history and clinical aspects

natural history and clinical aspects

WHO classification

• Stage I: asymptomatic infection or lymphadenopathy

• Stage II: moderate infection

• Stage III: advanced infection

• Stage IV: severe infection

CDC classification (Centers for Disease Control and Prevention, Atlanta)

Category A, B and C

Definition of AIDS: depends on choice of classification

Different classifications

Page 18: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Module 2: Natural history and clinical aspects

natural history and clinical aspects

Classification used in the country

Page 19: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects

Module 2: Natural history and clinical aspects

natural history and clinical aspects

Definition of AIDS used in the country


Recommended